Voy vs ALTRcare: 27% Cheaper Per Month, the Full Dose, Both Molecules, and Three Senior Specialists
Voy's website lists ₹19,999 for four months of semaglutide to 1.7 mg, through an app. ALTRcare is ₹3,666 a month for semaglutide to the full 2.4 mg dose, with tirzepatide available, cold-chain delivery included, and a senior endocrinologist, internal medicine consultant or diabetologist on your case every month. Number for number, dated so you can check.
ALTRcare Medical Team
Clinical Editorial
Voy and ALTRcare sell the same molecule, semaglutide, two different ways. Voy sells a four-month app plan with a doctor consultation inside it. ALTRcare sells a senior specialist, with the medicine, cold-chain delivery and a direct WhatsApp line to that doctor built around the relationship, for less per month. We are ALTRcare, so every figure here is dated and taken from the two websites so you can verify it yourself.
Key takeaways
- Voy's listed price is ₹19,999 for four months, ₹5,000 a month. ALTRcare semaglutide is ₹3,666 a month (₹10,999 for 3 months). 27% less, with the doctor and delivery inside.
- ALTRcare prescribes semaglutide to the full 2.4 mg maintenance dose and tirzepatide to 15 mg. Voy's plan stops semaglutide at 1.7 mg and does not list tirzepatide.
- At ALTRcare you see one of three senior specialists, the same one every month. Voy's page describes a consultation and a care team.
- ALTRcare has no sales team. No repeat calls, no haggling, a no is a no.
Price
| Voy | ALTRcare | |
|---|---|---|
| Listed price | ₹19,999 for 4 months | ₹10,999 for 3 months |
| Per month | ₹5,000 | ₹3,666 |
| Six months | Not offered as a plan | ₹21,998 |
| Highest dose in plan | 1.7 mg | 2.4 mg, the full maintenance dose |
| Tirzepatide | Not on the page | Yes, ₹34,999 for 3 months |
| Included | Medication, app, consultation, coaching | Medication, senior specialist, monthly reviews, cold-chain delivery, WhatsApp line to your doctor, GST |
The full dose, and the second molecule
Semaglutide's weight-management dose is 2.4 mg; the trials behind the 15% average were run at 2.4 mg. Voy's four-month plan takes you to 1.7 mg, the step before, and ends. Plenty of people do well at 1.7 mg. If you are not one of them, the plan finishes one rung short of the fix, and the fix is usually one of two things a fixed plan cannot do: go to 2.4 mg and hold, or move to tirzepatide. ALTRcare's doctors do both, in the same programme, at a published price. Month four to six is where that decision gets made for most patients, and it is the reason we do not sell fixed-length plans.
Three senior specialists. No junior doctors, ever.
Every ALTRcare consultation is with one of three senior specialists, and the one who sees you first sees you every month after. Dr. Mujeeb Afzal, MD, DM Endocrinology, consultant endocrinologist, for the hormonal and thyroid side of weight. Dr. (Major) Bhavesh Talera, MRCP-MD (UK), FRCP, consultant in internal medicine, for the gut, liver, heart and everything a GLP-1 touches. Dr. Archana Rathi, diabetologist and medicine specialist, ex-Registrar at Bombay Hospital, for diabetes, PCOS and women's health. Between them the bench covers endocrinology, gastroenterology-level side-effect care, diabetes and women's health. There is no junior doctor, no rotating panel, no coach relaying your question to someone you have not met.
How we sell, because it is part of the care
The price is on the page before you speak to anyone. The assessment is free, the doctor consultation is free, and if the doctor thinks medication is not right for you, you are told so plainly and that is the end of it. There is no sales team. Nobody calls three times a day, nobody offers a limited-time price, nobody haggles, and if you say no or not now, you will not hear from us again unless you message us. We think a medical decision deserves quiet, and we think it is why our patients stay for the six months a result takes.
What Voy does well
Voy is a real clinic with Indian prescribers and a polished app. Their page carries a promise to refund you if you do not lose 10% of your body weight in six months, subject to their terms; 10% is roughly the clinical-trial average for semaglutide, so read it as a floor, not the 19 kg their assessment chart shows. If you want app-based coaching, semaglutide to 1.7 mg for four months and a refund clause, that is a legitimate choice. It is not the cheaper one, the stronger one, or the one with a senior specialist on your case.
Three questions to ask either of us
Will the same doctor see me every month, by name? What is the total for my likely maintenance dose, in writing, today? What happens if I say no? Ours: yes, one of three senior specialists; it is on the pricing page; nothing, you will not hear from us again.
Compare us properly
Take the free 2-minute assessment and book a free consultation with a senior specialist. Every price is on the pricing page, and no one will call you to close.
Frequently asked questions
Is ALTRcare cheaper than Voy?
Yes. ALTRcare semaglutide is ₹3,666 a month (₹10,999 for 3 months), with the doctor, delivery and support included. Voy's listed price is ₹19,999 for four months, ₹5,000 a month.
Is Voy legit in India?
Yes. Voy is a weight-loss clinic operating in India with Indian prescribers. This article compares what each programme offers.
Who are ALTRcare's doctors?
Dr. Mujeeb Afzal (MD, DM Endocrinology), Dr. (Major) Bhavesh Talera (MRCP-MD UK, FRCP, internal medicine) and Dr. Archana Rathi (diabetologist, ex-Registrar Bombay Hospital). Every consultation is with one of the three; there are no junior doctors.
Does Voy offer tirzepatide?
As of September 2026 their India page describes a semaglutide plan to 1.7 mg. ALTRcare prescribes both semaglutide to 2.4 mg and tirzepatide to 15 mg.
Will ALTRcare call me repeatedly after I fill the form?
No. There is no sales team. You get a free assessment and a free doctor consultation. If you decide not to proceed, nobody follows up unless you message first.
What does Voy's money-back promise cover?
Their page states a refund if you do not lose 10% of body weight in six months, subject to their terms. That is roughly the clinical trial average for semaglutide.
Ready to take the next step?
Take the free 2-minute eligibility assessment. A doctor reviews it before anything is prescribed — no obligation.
This article is for general educational purposes and is not a substitute for personalised medical advice. GLP-1 medications are prescription-only and not suitable for everyone. Always consult a qualified doctor before starting, changing, or stopping any treatment.
